Adverse treatment effects |
Prednisolone (systemic) |
MMF |
IVIG |
Rituximab |
Azathioprine |
Total Patient Cases |
Sleep Disturbance |
3 |
|
|
|
|
3 |
Increased appetite |
4 |
|
|
|
|
4 |
Weight gain |
3 |
|
|
|
|
3 |
Increased BSLs |
2 |
|
|
|
|
2 |
Lethargy |
3 |
1 |
|
|
|
4 |
Agitation/irritability |
2 |
|
|
|
|
2 |
Osteopaenia/osteoporosis |
9 |
|
|
|
|
9 |
Lymphopaenia |
1 |
|
|
|
1* |
2 |
Oral candidiasis |
7 |
|
|
|
|
7 |
Spontaneous Ecchymoses |
2 |
|
|
|
|
2 |
Gastric upset (nausea/vomiting/diarrhoea) |
3 |
4 |
|
|
|
7 |
Flare of infection (orchitis, CMV, HSV) |
4 |
4 |
|
|
1 |
9 |
Flare of Acne |
1 |
|
|
|
|
1 |
LFT derangement |
|
2 |
|
|
|
2 |
Shortness of Breath |
1 |
1 |
|
|
|
2 |
Cushingoidfacies |
5 |
|
|
|
|
5 |
Post inflammatory hyperpigmentation |
3 |
4 |
|
1 |
|
8 |
Patient perceived effects (discomfort/distress) |
2 |
2 |
|
|
|
4 |
Unaffordability |
|
|
|
1 |
|
1 |
Total side effect cases for each treatment |
55 |
20 |
|
2 |
|
77 |
Total patients (receiving treatment for pemphigus vulgaris) |
21 (n) |
17 |
2 |
7 |
|
|
n= total sample of patients with biopsy proven pemphigus vulgaris |
*severe life threatening lymphopaenia (<0.2) with reduced T- cell subsets (CD4 and CD8 counts) for single case of MMF tx |
|
|